Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00056134 · COMPLETED

Trial details

NCT number: NCT00056134
Sponsor: University Hospital Erlangen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2002-10-01
Primary completion: 2011-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.